266 related articles for article (PubMed ID: 33752492)
1. Analysis of Mortality in Patients Treated With Phenylephrine in Septic Shock.
Patel VV; Sullivan JB; Cavanaugh J
J Pharm Pract; 2023 Feb; 36(1):15-18. PubMed ID: 33752492
[TBL] [Abstract][Full Text] [Related]
2. Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.
Arishi H; AlQahtani S; Tamim H; Sadat M; Alenezi FZ; Bin Humaid F; AlWehaibi W; Arabi YM
J Crit Care; 2022 Dec; 72():154121. PubMed ID: 35908329
[TBL] [Abstract][Full Text] [Related]
3. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
Toro C; Ohnuma T; Komisarow J; Vavilala MS; Laskowitz DT; James ML; Mathew JP; Hernandez AF; Goldstein BA; Sampson JH; Krishnamoorthy V
Anesth Analg; 2022 Dec; 135(6):1245-1252. PubMed ID: 35203085
[TBL] [Abstract][Full Text] [Related]
4. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Heart Rate After Phenylephrine vs Norepinephrine Initiation in Patients With Septic Shock and Atrial Fibrillation.
Law AC; Bosch NA; Peterson D; Walkey AJ
Chest; 2022 Oct; 162(4):796-803. PubMed ID: 35526604
[TBL] [Abstract][Full Text] [Related]
6. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
[TBL] [Abstract][Full Text] [Related]
7. Does Switching Norepinephrine to Phenylephrine in Septic Shock Complicated by Atrial Fibrillation With Rapid Ventricular Response Improve Time to Rate Control?
Haiduc M; Radparvar S; Aitken SL; Altshuler J
J Intensive Care Med; 2021 Feb; 36(2):191-196. PubMed ID: 31893966
[TBL] [Abstract][Full Text] [Related]
8. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
Bosch NA; Teja B; Wunsch H; Walkey AJ
Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
[No Abstract] [Full Text] [Related]
9. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
He D; Zhang L; Hu H; Gu WJ; Lu X; Qiu M; Li C; Yin H; Lyu J
Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
[TBL] [Abstract][Full Text] [Related]
10. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
Zechmeister C; Hurren J; McNorton K
Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis.
Durst MM; Eitzen EA; Benken ST
Ann Pharmacother; 2021 Aug; 55(8):970-979. PubMed ID: 33327736
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting.
Ragoonanan D; Allen B; Cannon C; Rottman-Pietrzak K; Bello A
Ann Pharmacother; 2022 Mar; 56(3):264-270. PubMed ID: 34109850
[TBL] [Abstract][Full Text] [Related]
15. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
17. Association of Vasopressor Choice with Clinical and Functional Outcomes Following Moderate to Severe Traumatic Brain Injury: A TRACK-TBI Study.
Toro C; Temkin N; Barber J; Manley G; Jain S; Ohnuma T; Komisarow J; Foreman B; Korley FK; Vavilala MS; Laskowitz DT; Mathew JP; Hernandez A; Sampson J; James ML; Goldstein BA; Markowitz AJ; Krishnamoorthy V;
Neurocrit Care; 2022 Feb; 36(1):180-191. PubMed ID: 34341913
[TBL] [Abstract][Full Text] [Related]
18. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
Ruslan MA; Baharuddin KA; Noor NM; Yazid MB; Noh AYM; Rahman A
West J Emerg Med; 2021 Feb; 22(2):196-203. PubMed ID: 33856300
[TBL] [Abstract][Full Text] [Related]
20. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Laderchi A; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2008; 12(6):R143. PubMed ID: 19017409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
